Pamoic acid[1][2] | |
---|---|
4-[(3-Carboxy-2-hydroxynaphthalen-1-yl)methyl]-3-hydroxynaphthalene-2-carboxylic acid |
|
Other names
Embonic acid |
|
Identifiers | |
CAS number | 130-85-8 |
PubChem | 8546 |
ChemSpider | 8228 |
UNII | 7RRQ8QZ38N |
EC number | 204-998-0 |
MeSH | Pamoic+acid |
ChEBI | CHEBI:50186 |
ChEMBL | CHEMBL177880 |
RTECS number | QL2180000 |
Beilstein Reference | 901319 |
Jmol-3D images | Image 1 Image 2 |
|
|
|
|
Properties | |
Molecular formula | C23H16O6 |
Molar mass | 388.37 g mol−1 |
Exact mass | 388.094688244 g mol-1 |
Melting point |
≥300 °C |
log P | 6.169 |
Acidity (pKa) | 2.675 |
Hazards | |
EU classification | Xi |
R-phrases | R36/37/38 |
S-phrases | S26 S36 |
Main hazards | Causes skin irritation Causes serious eye irritation |
Except where noted otherwise, data are given for materials in their standard state (at 25 °C, 100 kPa) | |
Infobox references |
Pamoic acid, also called embonic acid, is a naphthoic acid derivative. Salts and esters of pamoic acid are known as pamoates or embonates. It can be prepared by the reaction of 2-hydroxy-3-naphthoic acid with formaldehyde. In pharmacology, the salt form of pamoic acid (pamoate ion) can be used as a counter ion of a drug compound to increase the solubility of the drug in water.[3] The presence of multiple oxygen atoms enables significant hydrogen bonding to occur. Hydrogen bonds facilitate the dissolution of compounds in water.
It was demonstrated that pamoic acid has agonist activity for the orphan G protein-coupled receptor GPR35 by which it activates ERK and beta-arrestin2, and causes antinociceptive activity. Although (like other drug salts) it has been considered an inactive compound by the FDA, these recent data suggest that its use may be reexamined.